The Claim
Biogenic lipid-induced senescence is associated with upregulation of the anti-apoptotic proteins BCL2L1 and BCL2L2, resulting in resistance to cell death and persistence of senescent cells in tissues under mitochondrial stress.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When cells enter a senescent state due to biogenic lipids, levels of BCL2L1 and BCL2L2 proteins increase, which prevents cell death and allows these cells to remain in tissues despite mitochondrial stress.
See the scientific wording
Biogenic lipid-induced senescence (BLIS) is associated with upregulation of anti-apoptotic proteins BCL2L1 and BCL2L2, which confer resistance to cell death and may enable senescent cells to persist in tissues despite mitochondrial stress.
Damaged fats in fat tissue release toxic byproducts that attack DNA and mitochondria, causing cells to stop dividing and enter a persistent old state. These damaged cells survive because they produce special proteins that block the cell death signal, allowing them to linger and release harmful signals into surrounding tissue.
What the research says
1 studyWhen fat cells get damaged by certain lipid byproducts, they turn into old, dysfunctional cells that don’t die easily—this study shows they do this by making more BCL2L1 and BCL2L2 proteins, which act like bodyguards against cell death.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.